Bergmann Marcel, Caubet Jean-Christoph
Department of Pediatrics, Division of Pediatric Allergy, Geneva University Hospital, Geneva, Switzerland.
Curr Pharm Des. 2016;22(45):6832-6851. doi: 10.2174/1381612822666160926105533.
Suspicion for drug hypersensitivity (DH) is a common reason for children's referral to an allergy department, with β-lactam antibiotics and nonsteroidal anti-inflammatory drugs (NSAIDs) as the most frequently involved drugs. The prevalence of DH in children remains not well defined as epidemiologic studies in children are lacking, and the most of those take into account adverse drug reactions (ADR) without a systematic allergy work-up to confirm or exclude hypersensitivity. The clinical history is mandatory in order to classify the reaction as being immediate or non-immediate and then to subsequently adapt the allergy work-up. Mainly due to the lack of studies, the same guidelines used for diagnosis of drug allergy in adults are generally used in the pediatric population, and the diagnosis is based mainly on in vivo tests (i.e. skin tests and/or drug provocation test) and rarely on in vitro tests. However, specific aspects of management of DH in children have been recently highlighted.
怀疑药物过敏(DH)是儿童转诊至过敏科的常见原因,其中β-内酰胺类抗生素和非甾体抗炎药(NSAIDs)是最常涉及的药物。由于缺乏儿童流行病学研究,儿童DH的患病率仍未明确界定,而且大多数此类研究考虑的是药物不良反应(ADR),并未进行系统的过敏检查以确认或排除过敏反应。为了将反应分类为速发型或非速发型,进而调整过敏检查,临床病史是必不可少的。主要由于缺乏研究,儿科人群通常采用与成人药物过敏诊断相同的指南,诊断主要基于体内试验(即皮肤试验和/或药物激发试验),很少基于体外试验。然而,儿童DH管理的具体方面最近已受到关注。